TGFB1 and central nervous system cancer: SMC4 mRNA expression correlated positively with both early TGFβ-activated and delayed TGFβ-induced gene signatures (Figure 6a), suggesting that SMC4 promotes glioma cell aggressiveness and activates the TGFβ signaling pathway.